BioXcel Therapeutics, Inc. Quarterly Inventory, Net in USD from Q1 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
BioXcel Therapeutics, Inc. quarterly Inventory, Net history and growth rate from Q1 2022 to Q2 2024.
  • BioXcel Therapeutics, Inc. Inventory, Net for the quarter ending June 30, 2024 was $2.68M, a 39.2% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.68M +$755K +39.2% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.44M +$487K +24.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.99M +$6K +0.3% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $2.02M +$610K +43.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.93M +$530K +38% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.95M +$1.27M +186% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.99M Dec 31, 2022 10-K 2024-03-22
Q3 2022 $1.41M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $1.4M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $682K Mar 31, 2022 10-Q 2022-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.